ArticleMedicine2026
Identifying head and neck squamous cell carcinoma: HPV-associated signature by integrating bulk and single-cell sequencing data.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although several biomarkers can predict human papillomavirus (HPV) status in head and neck squamous cell carcinoma (HNSC), their accuracy is low. We assessed the HPV status of HNSC using a Scissor algorithm in conjunction with bulk sequencing and single-cell sequencing data. A Scissor scoring system was constructed for predicting HPV status using the gene set variation analysis algorithm. The biological functions and signaling pathways influencing the Scissor scoring model were described using correlation analysis and functional annotation. We used the Scissor algorithm to identify 1070 HPV-positive cells in single-cell sequencing data based on HPV status and then screened out genes that were significantly expressed in the Scissor-positive cells. We then constructed a Scissor score model using the 43 genes specifically expressed in Scissor-positive cells. The model had high accuracy in predicting HPV status in HNSC patients (area under curve in the discovery set: 86.6%, area under curve in the validation set: 96.1% and 79.8%). We also found that patients with higher Scissor scores had better outcomes, higher tumor mutational burden and tumor neoantigen burden, higher levels of immune checkpoint infiltration, and more cytotoxic T cell infiltration, and better outcomes with radiotherapy and immunotherapy. We constructed a predictive model that can accurately predict HPV status in patients with HNSC with greater accuracy than most current biomarkers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.